Patents by Inventor Thomas Proft

Thomas Proft has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANALYTICAL AND THERAPEUTIC METHODS AND COMPOSITIONS, AND USES THEREOF
    Publication number: 20200181207
    Abstract: The invention generally relates to compositions and methods for treating, detecting and assisting in the diagnosis of Streptococcus pyogenes infection, of rheumatic fever or of poststreptococcal glomerulonephritis (PSGN), and compositions and methods for assessing the propensity for developing rheumatic fever or PSGN in subjects in need thereof. Recombinant polypeptides, including recombinant Streptococcus pyogenes SpnA polypeptides, and compositions comprising such polypeptides, for use in such methods are also provided.
    Type: Application
    Filed: April 26, 2018
    Publication date: June 11, 2020
    Applicant: AUCKLAND UNISERVICES LIMITED
    Inventors: Nicole J MORELAND, Paul Gary YOUNG, Thomas PROFT
  • Superantigens SMEZ-2, SPE-G, SPE-H and SPE-J and uses thereof
    Patent number: 7491402
    Abstract: The invention provides superantigens SMEZ-2, SPE-G, SPE-H and SPE-J, as well as polynucleotides which encode them. Such superantigens have, inter alia, diagnostic and therapeutic application.
    Type: Grant
    Filed: November 24, 2004
    Date of Patent: February 17, 2009
    Assignee: Auckland Uniservices Limited
    Inventors: John David Fraser, Thomas Proft
  • Streptococcal superantigens spe-l and spe-m
    Publication number: 20060240044
    Abstract: The invention provides superantigens SPE-L and SPE-M, and their functional equivalents. In addition, the invention relates to nucleic acid molecules encoding the superantigens and/or their functional equivalents, and variant nucleic acids. The invention also provides diagnostic and therapeutic applications based on such superantigens and nucleic acid molecules.
    Type: Application
    Filed: May 9, 2003
    Publication date: October 26, 2006
    Inventors: John Fraser, Thomas Proft
  • Superantigens
    Publication number: 20050153376
    Abstract: The invention provides superantigens SMEZ-2, SPE-G, SPE-H and SPE-J, as well as polynucleotides which encode them. Such superantigens have, inter alia, diagnostic and therapeutic application.
    Type: Application
    Filed: November 24, 2004
    Publication date: July 14, 2005
    Inventors: John Fraser, Thomas Proft